KBC Group NV Buys 23,582 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

KBC Group NV increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 207,840 shares of the company’s stock after acquiring an additional 23,582 shares during the quarter. KBC Group NV’s holdings in GE HealthCare Technologies were worth $16,249,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of GEHC. D1 Capital Partners L.P. bought a new position in shares of GE HealthCare Technologies during the third quarter worth $268,159,000. Van ECK Associates Corp acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $208,513,000. State Street Corp lifted its holdings in GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after acquiring an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in GE HealthCare Technologies during the third quarter worth about $93,713,000. Finally, Geode Capital Management LLC grew its stake in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock valued at $1,026,898,000 after acquiring an additional 733,819 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.4 %

GE HealthCare Technologies stock opened at $87.78 on Wednesday. The company has a market cap of $40.10 billion, a price-to-earnings ratio of 24.12, a P/E/G ratio of 2.88 and a beta of 1.11. The firm has a 50-day moving average of $82.55 and a 200-day moving average of $84.90. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a one year low of $72.50 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.99 earnings per share. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Analysts Set New Price Targets

Several research firms have recently weighed in on GEHC. Evercore ISI lifted their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.00.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.